Tefose 63

Suppocire® AS2 Pellets is a hard fat suppository base with modified monoglyceride content recommended for hydrophilic APIs requiring fast release.

Suppocire® BM Pellets is a hard fat suppository base with excellent chemical compatibility and high crystallization rate. A versatile base with precedence of use with a wide range of APIs.

Suppocire® BS2X Pellets is a hard fat suppository base containing polysorbate additive to improve dispersion of hydrophilic APIs in aqueous solutions or hydroalcoholic extracts.

Suppocire® NAI 25 A Pellets is a hard fat suppository base optimized for the formulation of analgesics and antipyretics. Confers high mechanical resistance and yields harder suppository units.

Suppocire® NB Pellets is a hard fat suppository base with intermediate melting point. Confers high mechanical resistance and yields harder suppository units.

Tefose® 1500 (mixture of PEG-6 stearate and PEG-32 stearate) is a  nonionic oil-in-water emulsifier for topical formulations that provides high stability in topical fluid lotions and light emulsions over a wide pH range.

Transcutol® HP (diethylene glycol monoethyl ether) is the highest-purity grade solvent and solubilizer for solubility and bioavailability enhancement for oral and alternative routes (parenteral, nasal, ophthalmic formulations).

Transcutol® P (D=diethylene glycol monoethyl ether) a high-purity solvent and powerful solubilizer associated with skin penetration enhancement in topical dosage forms.

Transcutol® V (diethylene glycol monoethyl ether) is a high-purity solvent for oral, topical (spot-on, pour-on) and parenteral veterinary medicines. No Maximum Residue Limit for use in food-producing animals.

Labrafac™ MC60 (glycerol monocaprylocaprate) is a water-insoluble surfactant used in oral lipid-based formulation for bioavailability enhancement of poorly water-soluble, and poorly permeable drugs. It acts as a solubilizer and as an intestinal permeation enhancer.

Emulfree® Duo is a ready-to-use system. It has been designed to stabilize the oil phase within a bi-gel, an emerging topical formulation, by ensuring fine and homogeneous dispersion in the aqueous phase. As a PEG-free excipient, it is ideal for sensitive skins and mucosea.

Gelucire® 59/14 is a mixture of lauroyl PEG-32 glycerides and PEG 6000 and has surfactant properties. It is a self-emulsifying excipient used for oral bioavailability enhancement of poorly water-soluble drugs, thanks to its high solubilizing capacity.

Discover Gelucire® 59/14, an add-on in Gattefossé Gelucire® range, for oral bioavailability enhancement

Providing high-quality functional excipients

Our lipid excipients are manufactured using vegetable oils (including corn, apricot kernel or coconut oil), a wide array of plant-derived fatty acids, and alcohols such as polyglycerol, fatty alcohols, polyethylene glycol and propylene glycol.

Depending on the raw materials used, the esterification reaction leads to solid, semi-solid, or liquid excipients. The fatty acid chain length, the composition in terms of mono-, di- and triglycerides and alcohol-esters impact the end-product physico-chemical and functional properties.

 
Find out quickly the excipient you are looking for! This updated version has been enriched with the precedence of use of our excipients.

Discover Labrafac™ MC60, glycerol monocaprylocaprate, an oral bioavailability enhancer.

The four Technical Centers of Excellence of Gattefossé, based in France, the United States, China and India, help our customers worldwide in their formulation projects, from concept to commercialization. Their core missions are to provide technical support, troubleshoot and share their scientific knowledge on the use of lipid-based excipients.

Discover our brand new excipient Emulfree® Duo, a ready-to-use stabilizing agent, enabler of bi-gel, an emerging topical dosage form.